Literature DB >> 28379372

The Microbiological Landscape of Anaerobic Infections in Hidradenitis Suppurativa: A Prospective Metagenomic Study.

Hélène Guet-Revillet1,2,3,4, Jean-Philippe Jais1,5, Marie-Noelle Ungeheuer6, Hélène Coignard-Biehler1,4,7, Sabine Duchatelet1,8, Maïa Delage4,9, Thi Lam4,7,10, Alain Hovnanian1,8, Olivier Lortholary1,4,7, Xavier Nassif1,2,3,4, Aude Nassif4,7,10, Olivier Join-Lambert1,2,3,4.   

Abstract

BACKGROUND: Hidradenitis suppurativa (HS) is a frequent and severe disease of the skin, characterized by recurrent or chronic skinfold suppurative lesions with a high impact on quality of life. Although considered inflammatory, antimicrobial treatments can improve or lead to clinical remission of HS, suggesting triggering microbial factors. Indeed, mixed anaerobic microbiota are associated with a majority of HS lesions. Our aim in this study was to characterize the landscape of anaerobic infections in HS using high-throughput sequencing.
METHODS: We sampled and cultured 149 lesions and 175 unaffected control skinfold areas from 65 adult HS patients. The microbiome of 80 anaerobic lesions was compared to that of 88 control samples by 454 high-throughput sequencing after construction of 16S ribosomal RNA gene libraries.
RESULTS: Bacterial cultures detected anaerobes in 83% of lesions vs 53% of control samples, combined with milleri group streptococci and actinomycetes in 33% and 26% of cases, respectively. High-throughput sequencing identified 43 taxa associated with HS lesions. Two gram-negative anaerobic rod taxa, Prevotella and Porphyromonas, predominated, contrasting with a reduced abundance of aerobic commensals. These rare taxa of normal skinfold microbiota were associated with lesions independently of gender, duration and familial history of HS, body mass index, and location. Two main additional taxa, Fusobacterium and Parvimonas, correlated with the clinical severity of HS.
CONCLUSIONS: In this study we reveal the high prevalence and particular landscape of mixed anaerobic infection in HS, paving the way for rationale targeted antimicrobial treatments.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Fusobacterium; Porphyromonas; Prevotella; hidradenitis suppurativa; soft tissue and skin infections

Mesh:

Year:  2017        PMID: 28379372     DOI: 10.1093/cid/cix285

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  26 in total

Review 1.  Hidradenitis Suppurativa: Causes, Features, and Current Treatments.

Authors:  Caroline Vinkel; Simon Francis Thomsen
Journal:  J Clin Aesthet Dermatol       Date:  2018-10-01

2.  Societal Implications of the Internet of Pathogens.

Authors:  Alexander L Greninger
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

Review 3.  [Pathogenesis of hidradenitis suppurativa/acne inversa].

Authors:  G Nikolakis; G Kokolakis; K Kaleta; K Wolk; R Hunger; R Sabat; C C Zouboulis
Journal:  Hautarzt       Date:  2021-07-06       Impact factor: 0.751

Review 4.  Hidradenitis suppurativa.

Authors:  Robert Sabat; Gregor B E Jemec; Łukasz Matusiak; Alexa B Kimball; Errol Prens; Kerstin Wolk
Journal:  Nat Rev Dis Primers       Date:  2020-03-12       Impact factor: 52.329

Review 5.  Are Bacteria Infectious Pathogens in Hidradenitis Suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017.

Authors:  Haley B Naik; Aude Nassif; Mayur S Ramesh; Gregory Schultz; Vincent Piguet; Afsaneh Alavi; Michelle A Lowes
Journal:  J Invest Dermatol       Date:  2018-11-08       Impact factor: 8.551

Review 6.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

7.  Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.

Authors:  Samuel Der Sarkissian; Schapoor Hessam; Joslyn S Kirby; Michelle A Lowes; Dillon Mintoff; Haley B Naik; Hans Christian Ring; Nisha Suyien Chandran; John W Frew
Journal:  JAMA Dermatol       Date:  2022-03-01       Impact factor: 11.816

8.  A systematic review and critical appraisal of metagenomic and culture studies in hidradenitis suppurativa.

Authors:  Samuel C Williams; John W Frew; James G Krueger
Journal:  Exp Dermatol       Date:  2020-08-11       Impact factor: 4.511

9.  A systematic literature review of the human skin microbiome as biomarker for dermatological drug development.

Authors:  T Niemeyer-van der Kolk; H E C van der Wall; C Balmforth; M B A Van Doorn; R Rissmann
Journal:  Br J Clin Pharmacol       Date:  2018-07-19       Impact factor: 4.335

10.  Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature.

Authors:  Lauren K Hoffman; Lewis E Tomalin; Gregory Schultz; Michael D Howell; Niroshana Anandasabapathy; Afsaneh Alavi; Mayte Suárez-Fariñas; Michelle A Lowes
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.